Free Trial

Amphastar Pharmaceuticals (AMPH) Competitors

Amphastar Pharmaceuticals logo
$23.36 +0.02 (+0.09%)
As of 12:19 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

AMPH vs. ADMA, PCVX, KRYS, RYTM, CYTK, PTCT, ZLAB, ACAD, MRUS, and ACLX

Should you be buying Amphastar Pharmaceuticals stock or one of its competitors? The main competitors of Amphastar Pharmaceuticals include ADMA Biologics (ADMA), Vaxcyte (PCVX), Krystal Biotech (KRYS), Rhythm Pharmaceuticals (RYTM), Cytokinetics (CYTK), PTC Therapeutics (PTCT), Zai Lab (ZLAB), ACADIA Pharmaceuticals (ACAD), Merus (MRUS), and Arcellx (ACLX). These companies are all part of the "pharmaceutical products" industry.

Amphastar Pharmaceuticals vs. Its Competitors

Amphastar Pharmaceuticals (NASDAQ:AMPH) and ADMA Biologics (NASDAQ:ADMA) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, valuation, earnings, risk and dividends.

Amphastar Pharmaceuticals currently has a consensus price target of $32.33, indicating a potential upside of 38.40%. ADMA Biologics has a consensus price target of $27.67, indicating a potential upside of 55.26%. Given ADMA Biologics' stronger consensus rating and higher possible upside, analysts plainly believe ADMA Biologics is more favorable than Amphastar Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Amphastar Pharmaceuticals
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25
ADMA Biologics
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33

Amphastar Pharmaceuticals has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500. Comparatively, ADMA Biologics has a beta of 0.43, meaning that its share price is 57% less volatile than the S&P 500.

ADMA Biologics has a net margin of 45.01% compared to Amphastar Pharmaceuticals' net margin of 19.38%. ADMA Biologics' return on equity of 47.16% beat Amphastar Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Amphastar Pharmaceuticals19.38% 22.20% 10.40%
ADMA Biologics 45.01%47.16%30.51%

In the previous week, ADMA Biologics had 11 more articles in the media than Amphastar Pharmaceuticals. MarketBeat recorded 16 mentions for ADMA Biologics and 5 mentions for Amphastar Pharmaceuticals. ADMA Biologics' average media sentiment score of 0.87 beat Amphastar Pharmaceuticals' score of 0.44 indicating that ADMA Biologics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Amphastar Pharmaceuticals
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
ADMA Biologics
10 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

65.1% of Amphastar Pharmaceuticals shares are held by institutional investors. Comparatively, 75.7% of ADMA Biologics shares are held by institutional investors. 27.1% of Amphastar Pharmaceuticals shares are held by company insiders. Comparatively, 3.7% of ADMA Biologics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

ADMA Biologics has lower revenue, but higher earnings than Amphastar Pharmaceuticals. Amphastar Pharmaceuticals is trading at a lower price-to-earnings ratio than ADMA Biologics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Amphastar Pharmaceuticals$731.97M1.50$159.52M$2.768.46
ADMA Biologics$426.45M9.98$197.67M$0.8520.96

Summary

ADMA Biologics beats Amphastar Pharmaceuticals on 13 of the 17 factors compared between the two stocks.

Get Amphastar Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMPH vs. The Competition

MetricAmphastar PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.10B$3.92B$5.51B$8.92B
Dividend YieldN/A1.19%5.38%4.12%
P/E Ratio8.467.5026.2119.84
Price / Sales1.5011.29415.30113.63
Price / Cash4.596.4936.4957.06
Price / Book1.532.718.005.32
Net Income$159.52M-$109.62M$3.15B$248.42M
7 Day Performance-0.38%3.00%1.72%2.50%
1 Month Performance-7.95%8.97%4.63%5.53%
1 Year Performance-37.83%41.07%35.87%19.65%

Amphastar Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AMPH
Amphastar Pharmaceuticals
4.3532 of 5 stars
$23.36
+0.1%
$32.33
+38.4%
-39.4%$1.10B$731.97M8.462,028
ADMA
ADMA Biologics
4.078 of 5 stars
$18.21
+0.3%
$27.67
+51.9%
+54.8%$4.34B$426.45M21.42530
PCVX
Vaxcyte
1.8768 of 5 stars
$32.51
-0.2%
$136.50
+319.9%
-57.2%$4.20BN/A-8.15160News Coverage
Positive News
KRYS
Krystal Biotech
4.6213 of 5 stars
$137.46
-1.0%
$211.13
+53.6%
-23.7%$4.01B$290.52M33.04210Analyst Revision
RYTM
Rhythm Pharmaceuticals
3.9005 of 5 stars
$63.19
+0.7%
$77.31
+22.3%
+53.4%$3.99B$130.13M-22.49140
CYTK
Cytokinetics
4.278 of 5 stars
$33.04
-0.4%
$70.92
+114.7%
-38.5%$3.96B$18.47M-6.25250Positive News
PTCT
PTC Therapeutics
4.4123 of 5 stars
$48.84
-2.0%
$65.00
+33.1%
+55.9%$3.95B$806.78M7.501,410Analyst Revision
ZLAB
Zai Lab
3.38 of 5 stars
$34.97
+0.7%
$54.28
+55.2%
+103.4%$3.86B$398.99M-14.041,869Analyst Forecast
Insider Trade
Analyst Revision
Gap Up
ACAD
ACADIA Pharmaceuticals
4.6862 of 5 stars
$21.57
-2.5%
$27.88
+29.2%
+33.2%$3.70B$957.80M15.74510
MRUS
Merus
1.7976 of 5 stars
$52.60
-0.7%
$84.64
+60.9%
-3.3%$3.67B$36.13M-12.8937
ACLX
Arcellx
2.7845 of 5 stars
$65.85
+0.8%
$111.23
+68.9%
+20.7%$3.60B$107.94M-22.0280

Related Companies and Tools


This page (NASDAQ:AMPH) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners